- Brain hematomas—including epidural, subdural, and intracerebral hematomas—are increasingly recognized in clinical settings due to aging populations, rising head trauma incidents, and improved diagnostic imaging technologies such as CT and MRI
- The escalating prevalence of neurological disorders and traumatic brain injuries, combined with growing awareness among patients and medical professionals, is driving demand for advanced diagnostics, minimally invasive surgical techniques, and rehabilitation services
- North America dominated the brain hematomas market with the largest revenue share of 38.6% in 2024, supported by a mature healthcare infrastructure, high patient access to imaging modalities, and strong investment in neurosurgical technology. The U.S. continues to lead regional growth, leveraging AI‑enhanced imaging tools, neuro-navigation systems, and digital patient monitoring solutions
- Asia‑Pacific is expected to be the fastest‑growing region in the brain hematomas market during the forecast period, with a projected CAGR of 7.1%, driven by increasing urbanization, expanding healthcare coverage, and rising incomes in countries such as China, India, and Southeast Asia
- The subdural hematomas segment dominated the brain hematomas market with a market share of 46.7% in 2024, owing to its higher prevalence, particularly among the elderly and individuals with traumatic brain injuries. The widespread use of advanced imaging modalities, such as CT and MRI scans, has significantly improved early detection and diagnosis, contributing to increased treatment rates and market growth
